BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1937611)

  • 1. Immune status in ataxia telangiectasia.
    Datta U; Sehgal S; Kumar L; Kaur KJ; Walia BN; Chopra JS; Marwaha RK
    Indian J Med Res; 1991 Jun; 94():252-4. PubMed ID: 1937611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunodeficiency and infections in ataxia-telangiectasia.
    Nowak-Wegrzyn A; Crawford TO; Winkelstein JA; Carson KA; Lederman HM
    J Pediatr; 2004 Apr; 144(4):505-11. PubMed ID: 15069401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ataxia-telangiectasia patients presenting with hyper-IgM syndrome.
    Noordzij JG; Wulffraat NM; Haraldsson A; Meyts I; van't Veer LJ; Hogervorst FB; Warris A; Weemaes CM
    Arch Dis Child; 2009 Jun; 94(6):448-9. PubMed ID: 19224889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-year follow-up of 160 patients with ataxia-telangiectasia.
    Ersoy F; Berkel AI; Sanal O; Oktay H
    Turk J Pediatr; 1991; 33(4):205-15. PubMed ID: 1814037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum IgG subclass deficiency in ataxia-telangiectasia.
    Aucouturier P; Bremard-Oury C; Griscelli C; Berthier M; Preud'homme JL
    Clin Exp Immunol; 1987 May; 68(2):392-6. PubMed ID: 3652519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defective activation of the alternative pathway of complement in two brothers with ataxia-telangiectasia.
    Saint-Remy JM; Dent RG; Cole P
    J Clin Lab Immunol; 1981 Nov; 6(3):221-6. PubMed ID: 7338883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible neutrophil defect in ataxia telangiectasia.
    Kretschmer RR; Lopez Osuna M; Valenzuela RH
    Pediatrics; 1972 Jul; 50(1):147-50. PubMed ID: 5038091
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunologic and cytogenetic aspects of ataxia telangiectasia].
    Weemaes CM; Taalman RD; Van Munster PJ; Hustinx TW; Bakkeren JA; Scheres JM
    Tijdschr Kindergeneeskd; 1984 Aug; 52(4):164-9. PubMed ID: 6333737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical, biological and genetic study of 24 patients with ataxia telangiectasia from southern Tunisia].
    Triki C; Feki I; Meziou M; Turki H; Zahaf A; Mhiri C
    Rev Neurol (Paris); 2000 Jul; 156(6-7):634-7. PubMed ID: 10891797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leucocyte migration inhibition factor (LIF) production by lymphocytes of normal children, newborns, and children with immune deficiency.
    Hahn T; Levin S; Handzel ZT
    Clin Exp Immunol; 1976 Jun; 24(3):448-54. PubMed ID: 133010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classical ataxia telangiectasia patients have a congenitally aged immune system with high expression of CD95.
    Carney EF; Srinivasan V; Moss PA; Taylor AM
    J Immunol; 2012 Jul; 189(1):261-8. PubMed ID: 22649200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ataxia telangiectasia. Clinical and biological study in 17 cases].
    Ayache R; Najjar MF; Obeid H; Pousse H; Gueddiche MN
    Ann Biol Clin (Paris); 1994; 52(2):117-20. PubMed ID: 7528481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunoglobulin E in immunologic deficiency diseases. I. Relation of IgE and IgA to respiratory tract disease in isolated IgE deficiency, IgA deficiency, and ataxia telangiectasia.
    Polmar SH; Waldmann TA; Balestra ST; Jost MC; Terry WD
    J Clin Invest; 1972 Feb; 51(2):326-30. PubMed ID: 5009116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of CD3 antigen expression in patients with ataxia-telangiectasia.
    Boutin B; Wagner DK; Nelson DL
    Clin Exp Immunol; 1987 May; 68(2):320-30. PubMed ID: 3115644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative increase of T cells expressing the gamma/delta rather than the alpha/beta receptor in ataxia-telangiectasia.
    Carbonari M; Cherchi M; Paganelli R; Giannini G; Galli E; Gaetano C; Papetti C; Fiorilli M
    N Engl J Med; 1990 Jan; 322(2):73-6. PubMed ID: 2136770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer activity in two cases of ataxia telangiectasia.
    Kashiwa H; Kishi T; Kittaka E; Hyodo S; Karakawa T; Okada M; Matsushita T; Matsu-Ura R; Sakano T; Sawano K
    Acta Paediatr Scand; 1985 Sep; 74(5):819-23. PubMed ID: 4050431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ataxia telangiectasia with hepatocellular carcinoma in a 15-year-old girl and studies of her kindred.
    Weinstein S; Scottolini AG; Loo SY; Caldwell PC; Bhagavan NV
    Arch Pathol Lab Med; 1985 Nov; 109(11):1000-4. PubMed ID: 2996458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ataxia-telangiectasia presenting with a novel immunodeficiency.
    Perreault S; Bernard G; Lortie A; Le Deist F; Decaluwe H
    Pediatr Neurol; 2012 May; 46(5):322-4. PubMed ID: 22520355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ataxia-telangiectasia. X,14 translocation, progressive deterioration of lymphocyte numbers and function, and abnormal in vitro immunoglobulin production.
    Beatty DW; Arens LJ; Nelson MM
    S Afr Med J; 1986 Jan; 69(2):115-8. PubMed ID: 2417340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective in vitro production of influenza virus-specific cytotoxic T lymphocytes in ataxia-telangiectasia.
    Nelson DL; Biddison WE; Shaw S
    J Immunol; 1983 Jun; 130(6):2629-34. PubMed ID: 6189897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.